Skip to main content
Log in

Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Persistence of a left superior vena cava (LSVC) has been reported in 0.3%–0.4% of candidates for pacemaker (PM) or cardioverter-defibrillator (ICD) implantation. The aim of the study was to evaluate the clinical implications of LSVC persistence for proper device performance. We observed the prevalence of LSVC during a 15-year period. A total of 2077 consecutive patients underwent PM implantation over a 15-year period: 7 had persistent LSVCs (0.34%). Among 599 patients undergoing ICD implantation, 4 LSVCs (0.66%) were observed. Overall LSVC persistence was found in 11/2676 (0.41%) patients. The right superior vena cava was absent in 4/11 (36%) patients. The leads were placed from the left subclavian approach in 5/7 PM patients: 2 received an elective right sided approach due to physician preference. All ICD patients had the device placed left pectoral with a single-coil lead: defibrillation therapy was effective in the long term in all but one patient, who required the addition of a subcutaneous array. Left superior vena cava persistence in PM/ICD patients is similar to the general population (0.41% in our study). The left-sided implant may be skill-demanding during lead placement; however, this task can be accomplished in the majority of cases, with a reliable outcome in the short term and appropriate device performance at follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Los JA (1958) The development of the human pulmonary vein and the coronary sinus in the human embryo. Thesis, University of Leiden

  2. Van Mierop LHS (1969). Embryology of the heart. In: Netter FH (ed) The CIBA collection of medical illustrations, vol 5, pt 1. CIBA Pharmaceutical, Summit, NJ, pp 112–130

    Google Scholar 

  3. Meadows WR, Sharp JT (1965) Persistent left superior vena cava draining into the left atrium without arterial oxygen unsaturation. Am J Cardiol 16:273–279

    Article  PubMed  CAS  Google Scholar 

  4. Krukral JC (1971) Transvenous pacemaker failure due to anomalous venous return to the heart. Chest 59:4584–4561

    Google Scholar 

  5. Garcia L, Levine R, Kosowsky W, Lyon AF (1972) Persistent left superior vena cava complicating pacemaker insertion. Chest 61:396–397

    Article  PubMed  CAS  Google Scholar 

  6. Rubenfire M, Evangelista J, Wajszczuk WJ, Kantrowitz A (1974). Implication of a persistent left superior vena cava in transvenous pacemaker therapy and cardiac hemodynamic monitoring. Chest; 65145–65147

  7. Robbens EJ, Ruiter JH (1986) Atrial pacing via unilateral persistent left superior vena cava. Pacing Clin Electrophysiol 9:594–596

    Article  PubMed  CAS  Google Scholar 

  8. Dirix LY, Kersschot IE, Fierens H, Goethals MA, Van Daele G, Claessen G (1988) Implantation of a dual chamber pacemaker in a patient with persistent left superior vena cava. Pacing Clin Electrophysiol 11:343–345

    Article  PubMed  CAS  Google Scholar 

  9. Zerbe F, Bornakowski J, Sarnowski W (1992) Pacemaker electrode implantation in patients with left superior vena cava. Br Heart J 67:65–66

    Article  PubMed  CAS  Google Scholar 

  10. Rusk PA, Bexton JM, Mc Comb JM (1996) Persistent left-sided and absent right sided superior vena cava complicating pacemaker insertion. Heart 75:413

    Article  PubMed  CAS  Google Scholar 

  11. Brooks R, Jackson G, Mc Govern BA, Ruskin JN (1995) Transvenous cardioverter-defibrillator implantation via persistent left superior vena cava. Am Heart J 129:195–197

    Article  PubMed  CAS  Google Scholar 

  12. Hellestrand KJ, Ward DE, Bexton RS, Camm AJ (1982) The use of active fixation electrodes for permanent endocardial pacing via a left superior vena cava. Pacing Clin Electrophysiol 5:180–184

    Article  PubMed  CAS  Google Scholar 

  13. Biffi M, Boriani G, Bronzetti G, Frabetti L, Branzi A (2001) Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation. A 10-year experience. Chest 120:139–144

    Article  PubMed  CAS  Google Scholar 

  14. Movahed MR, Hashemzadeh M, Jamal M (2007) Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus. Heart Vessels 22(4):251–253

    Article  PubMed  Google Scholar 

  15. Lopez JA (2008) Transvenous biventricular pacing for cardiac resynchronization therapy in patients with persistent left superior vena cava and right superior vena cava atresia. Tex Heart Inst J 35(1):54–57

    PubMed  Google Scholar 

  16. Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A (2007) Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels 22(3):184–192

    Article  PubMed  Google Scholar 

  17. Epstein AE, Kay GN, Plumb VJ, Voshage-Stahl L, Hull ML (1995) Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak investigators. J Cardiovasc Electrophysiol 6:979–986

    Article  PubMed  CAS  Google Scholar 

  18. Favale S, Bardy GH, Pitzalis MV, Dicandia ICD, Traversa M, Rizzon P (1995) Transvenous defibrillator implantation in patients with persistent left superior vena cava and right superior vena cava atresia. Eur Heart J 16:704–707

    PubMed  CAS  Google Scholar 

  19. Markewitz A, Mattke S (1996) Right ventricular implantable cardioverter defibrillator lead implantation through a persistent left superior vena cava. Pacing Clin Electrophysiol 19:1395–1397

    Article  PubMed  CAS  Google Scholar 

  20. Paperini L, Pardini E, Genovesi Ebert A, Galli M (2004) Transvenous cardioverter-defibrillator implantation with a double-coil lead via left persistent vena cava. Ital Heart J 5:711–713

    PubMed  Google Scholar 

  21. Leng CT, Crosson JE, Calkins H, Berger RD (2001) Lead configuration for defibrillator implantation in a patient with congenital heart disease and a mechanical prosthetic tricuspid valve. Pacing Clin Electrophysiol 24:1291–1292

    Article  PubMed  CAS  Google Scholar 

  22. Tokano T, Pelosi F, Flemming M, Horwood L, Souza JJ, Zivin A, Knight BP, Goyal R, Man KC, Morady F, Strickberger SA (1998) Long-term evaluation of the ventricular defibrillation energy requirement J Cardiovasc Electrophysiol 9(9):916–920

    Article  PubMed  CAS  Google Scholar 

  23. Higgins SL, Rich DH, Haygood JR, Barone J, Greer SL, Meyer DB (1998) ICD restudy: results and potential benefit from routine predischarge and 2-month evaluation. Pacing Clin Electrophysiol. 21(2):410–417

    Article  PubMed  CAS  Google Scholar 

  24. Shukla H, Flaker H, Jayam V, Roberts D (2003) High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications. Pacing Clin Electrophysiol 26(1 Pt 1):44–48

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mauro Biffi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biffi, M., Bertini, M., Ziacchi, M. et al. Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation. Heart Vessels 24, 142–146 (2009). https://doi.org/10.1007/s00380-008-1091-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1091-4

Key words

Navigation